Clinical Trial - Trial ChiCTR2100050483
Access comprehensive clinical trial information for ChiCTR2100050483 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by China Academy of Chinese Medical Sciences and is currently Recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2100050483
Early Phase 1
Recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2100050483
View on Chinese Clinical Trial Registry
Untitled Trial
Study on the Mechanism of Yiqi Zengmian Fang and Huashibaidu Granules on New Coronary Pneumonia
Study Focus
Sponsor & Location
China Academy of Chinese Medical Sciences
China
Timeline & Enrollment
Early Phase 1
N/A
Aug 26, 2024
ICD-10 Classifications
COVID-19, virus identified
Viral pneumonia, unspecified
Other viral pneumonia
COVID-19, virus not identified
Pneumonia in viral diseases classified elsewhere
Data Source
Chinese Clinical Trial Registry
ChiCTR2100050483
Non-Device Trial